Enhancing employer coverage of smoking cessation treatment: A randomized trial of the Partners in Helping You Quit (PiHQ) program.


Journal

Preventive medicine
ISSN: 1096-0260
Titre abrégé: Prev Med
Pays: United States
ID NLM: 0322116

Informations de publication

Date de publication:
11 2020
Historique:
received: 26 03 2020
revised: 12 07 2020
accepted: 14 07 2020
pubmed: 22 7 2020
medline: 25 6 2021
entrez: 22 7 2020
Statut: ppublish

Résumé

The workplace is a key channel for delivering tobacco cessation treatment to a population. Employers can provide workplace-based programs and/or financial incentives such as health insurance benefits that cover the cost of treatment accessed outside the workplace. Little is known about the effect of combining these strategies. We tested the benefit of adding a workplace cessation program, Partners in Helping You Quit (PiHQ), to comprehensive health insurance coverage of smoking cessation medications by Partners HealthCare, a large Boston-based healthcare delivery system. PiHQ offers biweekly telephone-based behavioral support, additional automated calls, and medication care coordination for 3 months then monthly telephone monitoring for 9 months. In a pragmatic randomized trial, employees who smoked were informed about the insurance benefit, then randomly assigned (2:1) to PiHQ or to active referral to a free 3-month phone-based community program, Massachusetts Quitline (QL). Outcomes were assessed at 3, 6, and 12 months. During 2015-2018, 106 smokers (n = 73 PiHQ, n = 33 QL) enrolled (64% female; 75% white, 21% black; mean age 46 years, mean cigarettes/day = 13). More PiHQ than QL participants made a quit attempt by 3 months (82 vs. 61%, p < .02) and achieved the primary outcome, verified past 7-day cigarette abstinence at 6 months (31 vs. 12%, odds ratio 3.34, 95% CI, 1.05-10.60). Among participants using behavioral support, PiHQ participants completed more scheduled calls and rated counseling helpfulness higher than did QL participants. These results suggest that employers can enhance the impact of providing comprehensive health insurance coverage of smoking cessation medication by adding a phone-based worksite cessation program.

Identifiants

pubmed: 32693177
pii: S0091-7435(20)30240-1
doi: 10.1016/j.ypmed.2020.106216
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106216

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Nancy A Rigotti (NA)

Tobacco Research and Treatment Center, Division of General Internal Medicine and Mongan Institute, Massachusetts General Hospital, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America. Electronic address: Rigotti.Nancy@mgh.harvard.edu.

Jennifer H K Kelley (JHK)

Tobacco Research and Treatment Center, Division of General Internal Medicine and Mongan Institute, Massachusetts General Hospital, Boston, MA, United States of America.

Susan Regan (S)

Tobacco Research and Treatment Center, Division of General Internal Medicine and Mongan Institute, Massachusetts General Hospital, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.

Elizabeth Inman (E)

Tobacco Research and Treatment Center, Division of General Internal Medicine and Mongan Institute, Massachusetts General Hospital, Boston, MA, United States of America.

Sara Kalkhoran (S)

Tobacco Research and Treatment Center, Division of General Internal Medicine and Mongan Institute, Massachusetts General Hospital, Boston, MA, United States of America; Department of Medicine, Harvard Medical School, Boston, MA, United States of America.

Amy Flaster (A)

Department of Medicine, Harvard Medical School, Boston, MA, United States of America; Population Health, Partners HealthCare, Inc., Boston, MA, United States of America; Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.

Sreekanth K Chaguturu (SK)

Department of Medicine, Harvard Medical School, Boston, MA, United States of America; Population Health, Partners HealthCare, Inc., Boston, MA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH